{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:53:15Z","timestamp":1767207195059,"version":"build-2238731810"},"reference-count":49,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Med Report"],"DOI":"10.3892\/mmr.2018.9652","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T04:52:56Z","timestamp":1542084776000},"source":"Crossref","is-referenced-by-count":2,"title":["MicroRNA\u2011663 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells by directly targeting PAK4"],"prefix":"10.3892","author":[{"given":"Yingying","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nephrology, China\u2011Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Jiao","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, China\u2011Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, China\u2011Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"key20200713231552_b1-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2012.02.022","article-title":"The genetic basis of kidney cancer: Implications for management and use of targeted therapeutic approaches","volume":"61","author":"Linehan","year":"2012","journal-title":"Eur Urol"},{"key":"key20200713231552_b2-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"key20200713231552_b3-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2147\/OTT.S56370","article-title":"Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma","volume":"7","author":"Nerich","year":"2014","journal-title":"Onco Targets Ther"},{"key":"key20200713231552_b4-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/ajmg.10697","article-title":"Renal cancer: Cytogenetic and molecular genetic aspects","volume":"115","author":"Meloni-Ehrig","year":"2002","journal-title":"Am J Med Genet"},{"key":"key20200713231552_b5-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"key20200713231552_b6-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/CCO.0b013e3282f9782b","article-title":"Renal cell carcinoma","volume":"20","author":"Rini","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"key20200713231552_b7-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"key":"key20200713231552_b8-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.eururo.2014.04.006","article-title":"A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer","volume":"67","author":"Albiges","year":"2015","journal-title":"Eur Urol"},{"key":"key20200713231552_b9-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3892\/mmr.2014.2149","article-title":"MicroRNA-145 inhibits cell proliferation, migration and invasion by targeting matrix metallopeptidase-11 in renal cell carcinoma","volume":"10","author":"Wu","year":"2014","journal-title":"Mol Med Rep"},{"key":"key20200713231552_b10-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20200713231552_b11-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20200713231552_b12-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"key20200713231552_b13-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/jhg.2016.84","article-title":"Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma","volume":"62","author":"Kurozumi","year":"2017","journal-title":"J Hum Genet"},{"key":"key20200713231552_b14-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.gde.2018.01.001","article-title":"Emerging roles of microRNAs in cancer","volume":"48","author":"Vannini","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"key20200713231552_b15-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"115787","DOI":"10.18632\/oncotarget.23115","article-title":"MicroRNAs in cancer metastasis and angiogenesis","volume":"8","author":"Lou","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713231552_b16-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"e0192790","DOI":"10.1371\/journal.pone.0192790","article-title":"MicroRNA-19a and microRNA-19b promote the malignancy of clear cell renal cell carcinoma through targeting the tumor suppressor RhoB","volume":"13","author":"Niu","year":"2018","journal-title":"PLoS One"},{"key":"key20200713231552_b17-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"109877","DOI":"10.18632\/oncotarget.22436","article-title":"Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma","volume":"8","author":"Fujii","year":"2017","journal-title":"Oncotarget"},{"key":"key20200713231552_b18-mmr-19-01-0711","first-page":"173","article-title":"Downregulation of microRNA-1274a induces cell apoptosis through regulation of BMPR1B in clear cell renal cell carcinoma","volume":"39","author":"Yoshino","year":"2018","journal-title":"Oncol Rep"},{"key":"key20200713231552_b19-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.biopha.2017.10.136","article-title":"MicroRNA-543 promotes the proliferation and invasion of clear cell renal cell carcinoma cells by targeting Kr\u00fcppel-like factor 6","volume":"97","author":"Yang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"key20200713231552_b20-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1159\/000484394","article-title":"MicroRNA-30a-5p inhibits the growth of renal cell carcinoma by modulating GRP78 expression","volume":"43","author":"Wang","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"key20200713231552_b21-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11010-017-3102-1","article-title":"miRNA-200a induce cell apoptosis in renal cell carcinoma by directly targeting SIRT1","volume":"437","author":"Fu","year":"2018","journal-title":"Mol Cell Biochem"},{"key":"key20200713231552_b22-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3727\/096504017X15016337254632","article-title":"MicroRNA-384 inhibits the growth and invasion of renal cell carcinoma cells by targeting astrocyte elevated gene 1","volume":"26","author":"Song","year":"2018","journal-title":"Oncol Res"},{"key":"key20200713231552_b23-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"e454","DOI":"10.5301\/ijbm.5000261","article-title":"miR-411 functions as a tumor suppressor in renal cell cancer","volume":"32","author":"Zhang","year":"2017","journal-title":"Int J Biol Markers"},{"key":"key20200713231552_b24-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1002\/jcp.26347","article-title":"The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma","volume":"233","author":"He","year":"2018","journal-title":"J Cell Physiol"},{"key":"key20200713231552_b25-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"7648215","DOI":"10.1155\/2016\/7648215","article-title":"Increased serum level of MicroRNA-663 is correlated with poor prognosis of patients with nasopharyngeal carcinoma","volume":"2016","author":"Liang","year":"2016","journal-title":"Dis Markers"},{"key":"key20200713231552_b26-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3892\/mmr.2017.7129","article-title":"miR-663 promotes NPC cell proliferation by directly targeting CDKN2A","volume":"16","author":"Liang","year":"2017","journal-title":"Mol Med Rep"},{"key":"key20200713231552_b27-mmr-19-01-0711","first-page":"2819","article-title":"MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation","volume":"12","author":"Liu","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20200713231552_b28-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/jcp.24510","article-title":"miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence","volume":"229","author":"Jiao","year":"2014","journal-title":"J Cell Physiol"},{"key":"key20200713231552_b29-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1007\/s13277-015-4653-y","article-title":"MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200713231552_b30-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12943-015-0315-3","article-title":"miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer","volume":"14","author":"Zang","year":"2015","journal-title":"Mol Cancer"},{"key":"key20200713231552_b31-mmr-19-01-0711","first-page":"105","article-title":"Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells","volume":"24","author":"Pan","year":"2010","journal-title":"Oncol Rep"},{"key":"key20200713231552_b32-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","article-title":"Biology of the p21-activated kinases","volume":"72","author":"Bokoch","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"key20200713231552_b33-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jss.2015.02.035","article-title":"P21-activated kinase 1 and 4 were associated with colorectal cancer metastasis and infiltration","volume":"196","author":"Song","year":"2015","journal-title":"J Surg Res"},{"key":"key20200713231552_b34-mmr-19-01-0711","first-page":"322","article-title":"A two kinase-gene signature model using CDK2 and PAK4 expression predicts poor outcome in non-small cell lung cancers","volume":"63","author":"Wang","year":"2016","journal-title":"Neoplasma"},{"key":"key20200713231552_b35-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.3892\/ijo.2017.4122","article-title":"MicroRNA-485 inhibits malignant biological behaviour of glioblastoma cells by directly targeting PAK4","volume":"51","author":"Mao","year":"2017","journal-title":"Int J Oncol"},{"key":"key20200713231552_b36-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/jclinpath-2015-203330","article-title":"Prognostic significance of PAK4 expression in gastric cancer","volume":"69","author":"Kobayashi","year":"2016","journal-title":"J Clin Pathol"},{"key":"key20200713231552_b37-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1074\/mcp.M112.027052","article-title":"Systems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics","volume":"12","author":"Gnad","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"key20200713231552_b38-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"18622","DOI":"10.1073\/pnas.0907481107","article-title":"p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients","volume":"107","author":"Siu","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713231552_b39-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1016\/j.cellsig.2008.02.021","article-title":"A PAK4-LIMK1 pathway drives prostate cancer cell migration downstream of HGF","volume":"20","author":"Ahmed","year":"2008","journal-title":"Cell Signal"},{"key":"key20200713231552_b40-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"205.e13","DOI":"10.1016\/j.urolonc.2014.08.003","article-title":"p21-Activated kinase 4 predicts early recurrence and poor survival in patients with nonmetastatic clear cell renal cell carcinoma","volume":"33","author":"Liu","year":"2015","journal-title":"Urol Oncol"},{"key":"key20200713231552_b41-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1158\/1535-7163.MCT-16-0197","article-title":"Dual and specific inhibition of NAMPT and PAK4 By KPT-9274 decreases kidney cancer growth","volume":"15","author":"Abu Aboud","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"key20200713231552_b42-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1038\/cddis.2012.182","article-title":"Functional cooperativity by direct interaction between PAK4 and MMP-2 in the regulation of anoikis resistance, migration and invasion in glioma","volume":"3","author":"Kesanakurti","year":"2012","journal-title":"Cell Death Dis"},{"key":"key20200713231552_b43-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713231552_b44-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"e3155","DOI":"10.1038\/cddis.2017.561","article-title":"miR-106a-5p inhibits the cell migration and invasion of renal cell carcinoma through targeting PAK5","volume":"8","author":"Pan","year":"2017","journal-title":"Cell Death Dis"},{"key":"key20200713231552_b45-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1515\/cclm-2017-0861","article-title":"MicroRNAs as predictive biomarkers of response to tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma","volume":"56","author":"Kovacova","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"key20200713231552_b46-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbrc.2011.01.019","article-title":"MicroRNAs and their target gene networks in renal cell carcinoma","volume":"405","author":"Redova","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200713231552_b47-mmr-19-01-0711","first-page":"3727","article-title":"MicroRNAs in renal cell carcinoma: Implications for pathogenesis, diagnosis, prognosis and therapy","volume":"32","author":"Al-Ali","year":"2012","journal-title":"Anticancer Res"},{"key":"key20200713231552_b48-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1038\/onc.2011.629","article-title":"miR-663, a microRNA targeting p21(WAF1\/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma","volume":"31","author":"Yi","year":"2012","journal-title":"Oncogene"},{"key":"key20200713231552_b49-mmr-19-01-0711","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41419-017-0080-x","article-title":"miR-663 sustains NSCLC by inhibiting mitochondrial outer membrane permeabilization (MOMP) through PUMA\/BBC3 and BTG2","volume":"9","author":"Fiori","year":"2018","journal-title":"Cell Death Dis"}],"updated-by":[{"DOI":"10.3892\/mmr.2023.12995","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:00:00Z","timestamp":1681344000000},"record-id":"43881"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:47:49Z","timestamp":1594669669000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mmr.2018.9652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":49,"URL":"https:\/\/doi.org\/10.3892\/mmr.2018.9652","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]}}}